CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell...
Phase 2
Valencia, Spain and 49 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Valencia, Spain and 33 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Valencia, Spain and 209 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Valencia, Spain and 123 other locations
cemiplimab or docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
Valencia, Spain and 33 other locations
over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non...
Phase 1
Valencia, Spain and 38 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Valencia, Spain and 126 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Valencia, Spain and 137 other locations
"study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The...
Phase 2
Valencia, Spain and 54 other locations
The purpose of this study is to evaluate efficacy and safety of osimertinib (tablet) in combination with Datopotamab Deruxtecan (i.v. infusion) compa...
Phase 3
Valencia, Spain and 67 other locations
Clinical trials
Research sites
Resources
Legal